| トルコ | オーストリア | スペイン | |
| 骨切除術 | から $8,000 | から $25,000 | から $20,000 |
| 陽子線治療 | から $70,000 | から $80,000 | から $25,913 |
| 陽子線治療 | から $30,000 | から $80,000 | から $70,000 |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
| 乳がんに対する陽子線治療 | から $30,000 | から $55,000 | から $85,000 |
ムスタファ・ソラク医師は、ヒサール・ホスピタル・インターコンチネンタルにて、軟骨肉腫などの希少症例を含む様々な癌の治療を専門としています。
Dr. Mehmet Taner Ozdemir is an experienced orthopedic specialist with 7 years in the field. He focuses on oncology, orthopedic trauma, arthroscopic surgery, and bone and soft tissue tumors. He completed his medical and specialist training at GATA Faculty of Medicine in Ankara. He also received advanced training at the Hospital for Special Surgery in New York, USA.
Dr. Ozdemir is a member of the Turkish Orthopedics and Traumatology Association and the European Musculoskeletal Tumor Society. He has written five national and thirteen international publications. He is dedicated to improving orthopedic science. His skills include joint replacements, arthroscopies, and tumor surgeries.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Top chondrosarcoma doctors in Turkey include Prof. Mehmet Taner Ozdemir and Prof. Harzem Ozger. These specialists focus on orthopedic oncology – which means they treat bone cancers specifically. They use limb-sparing techniques so patients can keep mobility after tumor removal.
Bookimed Expert Insight: Top Turkish orthopedic oncologists often hold international fellowships from leading US cancer centers. For example, specialists at Anadolu Medical Center follow Johns Hopkins protocols for rare sarcomas. This ensures patients receive evidence-based care similar to top American hospitals at local rates.
Patient Consensus: Patients often mention feeling relieved after choosing specialists who focus entirely on bone oncology. They describe the hospital environment as modern and feel supported by the quick diagnostic process.
Qualified specialists in Turkey hold board certification in orthopedic oncology or medical oncology. They often belong to international groups like the American Society of Clinical Oncology (ASCO). These experts use tumor boards to plan intensive treatment for chondrosarcoma, which is a rare bone cancer.
Bookimed Expert Insight: Specialists at Hisar Intercontinental and Memorial Şişli often combine surgery with targeted immunotherapy. Dr. Mustafa Solak and Dr. Selman Dogan have experience managing rare bone cancers using these combined methods. This dual approach is essential because chondrosarcoma often resists standard chemotherapy.
Patient Consensus: Patients felt relieved when doctors explained every step of the bone reconstruction process clearly. They noticed that having a translator present during consultations made complex surgical details much easier to understand.
Turkish orthopedic oncologists prioritize limb-sparing surgery for chondrosarcoma to avoid amputation whenever possible. Specialists use bone grafts and modular endoprostheses – artificial joint replacements – to maintain limb function. Most senior surgeons have 20+ years of experience in complex musculoskeletal reconstruction.
Bookimed Expert Insight: Data shows that top Turkish specialists often hold dual certifications in orthopedics and oncology. For example, Dr. Mehmet Halici at Memorial Bahçelievler has 25+ years of experience in these complex surgeries. This combination is vital because the surgeon must remove the cancer while rebuilding the limb.
Patient Consensus: Patients often mention feeling relieved when doctors explain how custom implants will replace the bone. They appreciate that translators help them understand the complex steps of the reconstruction process clearly.
Yes, you can receive a second opinion for chondrosarcoma from Turkish orthopedic oncologists. These specialists review imaging and biopsy results to confirm if limb-sparing surgery is possible. Many experts have international training, providing research-backed alternatives to aggressive treatments typically offered elsewhere.
Bookimed Expert Insight: A second opinion here often changes the surgical approach for bone tumors. Turkish specialists like Dr. Mustafa Solak use insights from top US cancer centers. This helps patients find less invasive options that still focus on long-term health results.
Patient Consensus: Patients were relieved to find doctors who explained every step of the tumor removal. They felt supported because the medical teams handled all the difficult logistics and paperwork.
Turkish specialists treat chondrosarcoma, a type of bone cancer, using limb-sparing surgery and personalized reconstruction. Surgeons often use 3D-printed implants to replace removed bone. They also use MR-LINAC, which is radiation guided by real-time MRI scans to protect healthy tissue.
Bookimed Expert Insight: Top Turkish orthopedic oncologists often hold EUMS certifications. This means they meet strict European standards for bone cancer surgery. Centers in Istanbul often combine these surgical skills with PET-CT imaging. This combination helps doctors find tiny cancer cells that standard scans might miss.
Patient Consensus: Patients are often relieved that surgeons can avoid amputation using internal prostheses. Many describe the precision of the robotic systems as a key factor in their recovery. They also notice how quickly specialists coordinate between radiology and surgery teams.
医療はトルコ政府にとって重要な開発分野である。トルコ当局は、国民の健康管理は国家政策の絶対的な優先事項であるべきだと考えており、医療に年間約770億リラを支出している。
その結果、国内の28,000の医療機関が優れた医療を提供している。そのうち約50の施設は、世界中の医療サービスの質と安全性を向上させる国際機関であるJCI(国際医療機関評価機構)の認証を受けている。これらの施設は、認証取得数において最も高い水準を誇っている。比較すると、 イスラエルにはJCI認証を受けた医療機関が20施設あるのに対し、ドイツにはわずか10施設しかない。
| 通貨 | リラ(サービス料金の支払いは米ドルとユーロでも可能です) |
| 旅行に最適な時期 | 5月~10月 |
| 言語 | トルコ語(ほとんどの医療スタッフは英語を流暢に話します) |
| ビザ | 最低30日間の旅行には不要です。 |
| ヨーロッパとの時差 | 3時間 |
| アメリカとの時差 | 8時間 |
| 資本 | アンカラ |
| 医療ツーリズムセンター | イスタンブール |
| 人気のリゾート | アランヤ、アンタルヤ、ケメル、マルマリス |
トルコには、価格帯やサービスレベルが異なる様々なホテルがあります。トルコのホテルの水準は、チュニジア、モロッコ、エジプトのホテルと同等です。ほとんどの観光客は、食事付きの4つ星または5つ星ホテルを選びます。これらのホテルは、豊富な食事の選択肢、広々とした手入れの行き届いた敷地、子供から大人まで楽しめるエンターテイメントなど、快適な滞在に必要なすべてを提供しています。一部のホテルには、宿泊客が無料で利用できるウォーターパークがあります。予算重視の旅行者は、ハーフボードまたは食事なしの経済的な3つ星ホテルを予約することもできます。
トルコのリゾート地の最大の魅力は、長いビーチシーズンです。地中海沿岸では4月から11月まで、エーゲ海沿岸では5月から10月までがビーチシーズンとなります。泳ぐのに最も快適な時期は6月中旬から10月末までです。観光客が最も多く訪れるのは7月と8月で、この時期の気温は38℃、水温は27℃まで上昇します。
トルコへの渡航ビザには、いくつかの書類が必要です。必要な書類は、出発予定日の90日前から提出できます。必要な書類は以下のとおりです。